Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.39M Hold
15,100
0.09% 183
2025
Q4
$3.64M Hold
15,100
0.11% 142
2025
Q3
$4.13M Hold
15,100
0.12% 146
2025
Q2
$3.9M Buy
15,100
+10,100
+202% +$2.41M 0.1% 139
2025
Q1
$1.12M Buy
+5,000
New +$1.17M 0.06% 237

Other funds holding RMD

SIG Brokerage's RMD Position: Q1 2026 in Review

SIG Brokerage increased its ResMed (RMD) stake by 48% in Q1 2026, buying an estimated $244K and bringing the position to 3,016 shares worth $677K. The position accounts for 0.02% of the portfolio, ranked #488.

SIG Brokerage first reported a position in RMD in Q2 2025 and has held it in 4 quarters since. The position peaked at $949K in Q2 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • SIG Brokerage held 3,016 shares of ResMed worth $677K as of Q1 2026.
  • SIG Brokerage bought 981 ResMed shares in Q1 2026, an estimated $244K.
  • ResMed made up 0.02% of SIG Brokerage's portfolio in Q1 2026, its #488 holding.
  • SIG Brokerage first reported a position in ResMed in Q2 2025 and has held it in 4 quarters since.
  • SIG Brokerage's ResMed position peaked at $949K in Q2 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on SIG Brokerage's 13F filing for Q1 2026, filed 15 May 2026.